Clinical Trials Directory

Trials / Sponsors / Advenchen Laboratories, LLC

Advenchen Laboratories, LLC

Industry · 6 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
Active Not RecruitingA Study of AL8326 in Non-Small Cell Lung Cancer
Non-small Cell Lung Cancer
Phase 12022-05-19
RecruitingA Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors.
Solid Tumor
Phase 1 / Phase 22021-10-26
RecruitingPhase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial S
Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma
Phase 32017-08-15
UnknownPhase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or
Endometrial Carcinoma, Ovarian Carcinoma, Fallopian Tube Carcinoma
Phase 32015-12-01
TerminatedPhase 1/2a Evaluation of AL3818 in Subjects With Recurrent or Metastatic Endometrial, Ovarian or Cervical Canc
Endometrial Cancer, Ovarian Cancer, Cervical Cancer
Phase 1 / Phase 22015-11-01
AvailableCatequentinib in Patients Who Have Completed an Advenchen Study (A Compassionate Use Trial)
Sarcoma,Soft Tissue, Gynecologic Cancer
——